An overview of biosimilars for cancer, diabetes mellitus, rheumatoid arthritis and other immune-mediated diseases approved between 2016 and 2021-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An overview of biosimilars for cancer, diabetes mellitus, rheumatoid arthritis and other immune-mediated diseases approved between 2016 and 2021

Published:2022-01 Issue: Volume:4 Page:100356
ISSN:2211-7156
Container-title:Results in Chemistry
language:en
Short-container-title:Results in Chemistry

Author:

Priyarega Sivakumar,Natarajan Ramanathan

Publisher

Elsevier BV

Subject

General Chemistry

Reference64 articles.

1. Chapter 18 - Gold nanoparticles: an advanced drug delivery and diagnostic tool;Pandey,2020

2. Chapter 5 - Biotechnology-based pharmaceutical products;Deb,2019

3. Chapter 13 - Recombinant blood products and therapeutic enzymes: an update;Rajpoot,2020

4. Human insulin from recombinant DNA technology;Johnson;Science,1983

5. Advances in mammalian cell line development technologies for recombinant protein production;Lai;Pharmaceuticals,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New targeted pharmacotherapy and experimental therapies for inflammatory bowel disease;Journal of Integrative Medicine and Research;2024-07

2. The use of proteins and peptides-based therapy in managing and preventing pathogenic viruses;International Journal of Biological Macromolecules;2024-06

3. Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma;Journal of Materials Chemistry B;2024

4. Regulatory Considerations of Biosimilars in Cancer;Biosimilars for Cancer Treatment;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP